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Objective: To examine the gender distribution in ASD in adults compared with 
children and the impact of comorbid intellectual disability (ID) and attention- 
deficit/hyperactivity disorder (ADHD) on the male to female ratio (MFR).
Methods: We estimated the MFR and the male prevalence ratio (PR) for ASD 
in adults and children using the Medical Birth Registry of Norway, including all 
individuals born during 1967– 2011. We examined variation with age, comorbid 
ID and ADHD as defined by diagnoses in the Norwegian Patient Registry during 
2008– 2015 and/or a dispensed prescription for ADHD medication.
Results: The sample included 1,701,206 adults and 804,146 children, including 
8,995 (0.5%) adults and 8,056 (1.0%) children with ASD, 53,822 (3.2%) adults and 
26,967 (3.4%) children with ADHD and 9,178 (0.5%) adults and 5,038 (0.6%) chil-
dren with ID. The MFR for ASD was 3.67 in children and 2.57 in adults, corre-
sponding to a male PR in ASD of 1.54 (95% CI 1.53– 1.56) and 1.41 (1.39– 1.24), 
respectively. Comorbid ID decreased the MFR and the male PR in both adults and 
children, whereas comorbid ADHD significantly increased the male PR in chil-
dren. The MFR and the population prevalence of ASD, ADHD and ID decreased 
from children to younger adults and yet further to older adults.
Conclusion: We found a lower MFR and male PR in adults than in children. 
Findings suggest the strong male predominance seen in childhood/clinical 
studies of ASD diminishes in adult samples, possibly reflecting the influence of 
non- aetiological factors such as later diagnosis in females, diagnostic biases and 
diagnostic trends.
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1  |  INTRODUCTION
Male predominance is a consistent finding in studies of 
autism spectrum disorder (ASD), with male to female ra-
tios (MFR) or male: female odds ratio (MFOR; depending 
on type of study) as high as 4.2– 4.3, also in recent stud-
ies.1,2 This strong male predominance has fueled various 
causal hypotheses of ASD, eg testosterone exposure in 
utero, the extreme male brain theory3 and a female pro-
tective effect in ASD.4 The idea of a female protective ef-
fect in ASD comes from the finding that the MFR/MFOR 
seems to increase with level of ability. In samples of indi-
viduals with predominantly low ability (intelligence quo-
tient (IQ) below 70), the MFR has been reported as low 
as 1.8,5 rising to 4.2 in samples with a majority within the 
normal range of ability.1 The interaction between gender 
difference and ability has been interpreted as females pos-
sibly requiring a stronger neurodevelopmental impact to 
develop ASD. However, there is evidence that some of the 
male predominance in ASD could be a male ascertain-
ment bias.1 Studies have shown that females to a larger 
degree are not being detected and diagnosed with ASD de-
spite large difficulties.6- 9 Under detection of female ASD 
could be eg gender differences in the clinical presentation 
of ASD, assessment bias and diagnostic instruments being 
tailor- made to the male ASD presentation. Girls have dif-
ferent clinical presentations10 and it has also been shown 
that diagnostic instruments are not as sensitive to the fe-
male phenotype, creating considerably poorer diagnostic 
precision in females.11 In line with this, a meta- analysis 
indicated that the MFR/MFOR in children may be over-
estimated based on current studies, as studies with lower 
risk of ascertainment bias had a lower MFOR than studies 
with a higher risk of ascertainment bias.1 The same as-
certainment bias has been suggested in ADHD, where a 
lower MFR in adults than in children has been found,12 
possibly caused by later identification and gender barri-
ers to child and adolescent mental health services for girls 
with ADHD.13,14 Regarding adult ASD, there are some 
emerging studies, but we still know little of the natural 
development of ASD through the life course15 and even 
less about the gender distribution in adult ASD. Brugha 
et al. found an even stronger relationship between the 
level of ability and gender differences in adult ASD. Using 
an OR weighted for age, gender, ID and type or residence, 
they found an OR of 1.35 (95% CI 0.64– 2.83) for ASD in 
males relative to females with moderate to profound in-
tellectual disability (ID) but an OR of 8.97 (95% CI 2.20– 
36.52) and 8.62 (95% CI 2.2– 34.5) in adults with mild ID 
or borderline/normal intelligence.16,17 Their large con-
fidence intervals preclude firm conclusions, but the au-
thors hypothesized that the high male OR in adults with 
normal intelligence could stem partly from assessment 
bias and difficulties in diagnosing ASD particularly in 
higher functioning females. In a total population study in 
the Faroe Island, considerably more females were found 
in the second assessment, with a MFR of 2.7:1 in their 
15– 24- year- old sample,18 which could indicate that the 
same child- adult gender differences may exist in ASD as 
found in ADHD. The large differences in the number of 
females identified in the second vs. the first study in the 
Faroe Island could be several of the causes mentioned 
above, eg better identification, increased awareness for fe-
male ASD, impairment developing later in females etc.18 
There are thus great discrepancies between the few adult 
studies that have examined gender and adult ASD, from 
increased MFR/MFOR to lower MFR/MFOR relative to 
childhood studies. The cited adult studies included few in-
dividuals, and two employed active case- searching meth-
ods, producing estimates of MFR and MFOR respectively 
with very broad confidence intervals and carrying a high 
risk of ascertainment bias. There is thus a need for larger 
studies examining the MFR across the lifespan of ASD and 
how it is influenced by comorbid intellectual disability.
Significant outcomes:
• We found a lower male to female ratio (MFR) 
for ASD in adults (2.57) than in children (3.67) 
in the Norwegian Patient Registry.
• We found a decreasing registered prevalence of 
autism spectrum disorders (ASD) from children 
to younger adults and further to older adults in 
the general population.
• The adult prevalence of ASD in the Norwegian 
Patient Registry (for individuals aged 18– 
48  years and alive at the time of the registry 
linkage) was 0.5%.
Limitations:
• Information on autism spectrum disorders 
(ASD) and comorbid disorders were based on a 
national patient registry with clinical diagnoses 
that were not validated in the current study.
• The study was based on the diagnoses of ASD 
registered in a limited time window from 2008– 
2015. Individuals diagnosed before 2008 and 
not in contact with specialized health services 
in the years 2008– 2015 do not appear in the 
study as cases.
• The study was based on the Medical Birth 
Registry of Norway (MBRN) which was es-
tablished in 1967, and therefore only included 
adults up to age 48.
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1.1 | Aims of the study
The main aim of the present study was to estimate the 
MFR and the male prevalence ratio (PR) in adults com-
pared with children with ASD in a total population and 
to examine the impact of comorbid ID and/or ADHD. 
We furthermore examined the variation of the MFR and 
male PR with age and ASD subtypes to evaluate possible 
reasons for ASD MFR variation. Being a total population 
study, PR was used as the adjusted measure of gender 
ratio estimates rather than MFOR.19
2  |  MATERIALS AND METHODS
2.1 | Sample
The study population included all individuals born 
and registered in the Medical Birth Registry of Norway 
(MBRN), during 1967– 2011, who was living in Norway 
at record linkage in 2015 (n  =  2,486,088). Information 
from three nationwide population- based registries was 
linked to obtain information on diagnosis and medica-
tion: The MBRN, established in 1967,20 the Norwegian 
Prescription Database (NorPD), established in 200421 
and the Norwegian Patient Registry (NPR),22 with link-
able data from 2008. The NorPD registers all medical pre-
scriptions dispensed to individuals from any Norwegian 
pharmacy and includes the Anatomical Therapeutic 
Chemical (ATC) Classification System codes. The NPR 
includes information about diagnoses and interventions 
given to patients treated in secondary health care, in hos-
pitals and outpatient clinics. Diagnoses are registered 
by the International Classification of Diseases (ICD), 
version 10. Record linkage was performed using the na-
tional identification number unique to every Norwegian 
resident. Individuals born before 1967 are not part of 
the MBRN and could not be included. The study was ap-
proved by the Regional Committees for Medical Research 
Ethics in Norway (2011/2272) and reported according to 
guidelines suggested by the Strengthening the Reporting 
of Observational Studies in Epidemiology (STROBE) 
Initiative.23
2.2 | Variables
2.2.1 | Outcome: ASD with and without 
comorbid ID and/or ADHD
Diagnoses coded by F84 with subcategories (ICD- 10) were 
analysed jointly under the umbrella term autism spectrum 
disorders (ASD); defined as individuals registered in the 
NPR (2008– 2015) with the following ICD- 10 codes: F84.0– 
84.1+F84.5+F84.8– 84.9 (Table 3). We identified individ-
uals with ADHD if they were registered with an ADHD 
diagnosis (ICD- 10 code F90; NPR 2008– 2015) and/or hav-
ing been dispensed a prescription of ADHD medication 
during 2004– 2015 (NorPD). The ADHD medications iden-
tified were the central stimulants methylphenidate (N06B 
A04), racemic amphetamine (N06B A01) and dexamphet-
amine (N06B A02) and the non- stimulant drug atomoxe-
tine (N06B A09). Lisdexamphetamine (N06B A12) was not 
included as it was only introduced on the Norwegian mar-
ket in the fall of 2014. ID was defined as individuals reg-
istered in the NPR with any of the ICD- 10 codes: F70- 79.
Adults were individuals who were 18  years or more 
by the time of record linkage, ie born before 1998. In 
sub- analyses, we further divided adults into older (born 
1967– 1983) and younger (born 1984– 1997) adults. The 
childhood population was defined as individuals aged 
4– 17 years (born 1998– 2011) at linkage in 2015 and was 
further divided into younger and older children, age 
4– 10 years and age 11– 17 years.
The remaining population included all individuals who 
had not been dispensed neither an ADHD medication nor 
had an ASD, an ADHD nor an ID diagnosis, in the NorPD 
and NPR, respectively. Any individuals diagnosed with 
ASD, ADHD or ID before 2008 and not in contact with 
specialist health services in 2008– 2015, nor prescribed any 
ADHD medication in 2004– 2015 were included in the re-
maining adult population since it was not possible to iden-
tify their diagnoses.
2.2.2 | Measures and statistical analyses
We analysed the male to female ratio (MFR) for all ASD 
(including both ADHD and ID) and then split all ASD by 
ADHD status to analyse the impact of comorbid ADHD 
on the MFR. We then reran analyses by ID status, to ana-
lyse the impact of comorbid ID. We calculated the male 
prevalence ratio (PR) as the adjusted measure, which cor-
responds to the percentage increase in males in the clini-
cal population versus the non- clinical population. A PR of 
1.4 equals 40% more males than in the population with-
out the studied diagnoses. As diagnostic practices have 
changed considerably over the studied decades, we pre-
sent descriptive statistics of the overall registered preva-
lence of ASD, ADHD and ID and specifically for Asperger 
syndrome (AS) that was introduced as a diagnosis in 
1994.24 We analysed the MFR in younger (born 1984– 
1997) and older adults (born 1967– 1983) as well as for all 
children, children aged 4– 10 years and aged 11– 17 years 
separately. Finally, we analysed the MFR in the ASD sub-
types separately.
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We used the STATA command ‘binreg’ for the calcula-
tion of PR with gender as the exposure and with adjust-
ment for birth year (5- year periods, from 1967 to 1997, 
with 1967– 1973 as the reference). Statistical differences 
were based on evaluation of confidence intervals (CI), 
using 95% intervals as the range to evaluate significance.
3  |  RESULTS
3.1 | Study groups
A total of 1,701,206 adult individuals born during 1967– 
1997 and living in Norway at linkage in 2015 were in-
cluded. We identified 8,995 adults with any ASD (0.5%), 
53,822 adults with any ADHD (3.2%) and 9,178 adults 
with any ID (0.5%). There were 5,300 adults with ASD only 
(0.3%), 49,908 adults with ADHD only (2.9%), 2,512 adults 
with ADHD+ASD (0.1%) and 1,183 adults with ASD+ID 
(0.1%) in our study population (no ADHD). Very few had 
all three disorders, ASD+ADHD+ID, n = 328 (0.2‰), see 
Table 1. The adult population with no ASD, ADHD nor ID 
consisted of 1,684,543 individuals, 823,546 (49%) women. 
The mean age in 2015 for adults (born before 1998) for 
the ASD only group was 26.2 years, for the ASD+ADHD 
24.1 years and the remaining adults 33.1 years.
We identified 804,146 children (391,751 (48.7%) fe-
males), born 1998– 2011. We identified 8,056 (1.0%) chil-
dren with any ASD, 26,967 with any ADHD (3.4%) and 
5,038 with any ID (0.6%). The number of children with 
ASD only was 5,459 (0.7%), ADHD only 24,370 (3.0%) and 
2,597 had ADHD+ASD (0.3%). Only 357 (0.4‰) had all 
three disorders (ASD+ADHD+ID) (0.04%). The remain-
ing children with no ASD, ADHD nor ID consisted of 
792,314 individuals (388, 409 (49.6%) females).
3.2 | Gender ratios in adults – impact of 
ADHD and ID
Table 1 and Figure 1 show the MFR and the male prev-
alence ratio in ASD with and without comorbid ADHD 
and ID as compared with males in the population without 
ASD, ADHD and ID (Table 1 and Figure 1). The overall 
MFR for adult ASD was 2.57 and the PR 1.41 (95% con-
fidence interval (CI) 1.39– 1.42). The overall MFR for 
ASD only (excluding ADHD and ID) was 2.62 with a PR 
of 1.41 (1.39– 1.44). The group with comorbid ADHD but 
no ID had an MFR of 2.75 with a PR of 1.43 (1.39– 1.47). 
The lowest MFR of 1.93, PR 1.31 (1.25– 1.37) was seen 
in the group with ID and ASD (no ADHD) whereas the 
highest MFR among adults was found in the group with 
ASD+ADHD+ID: 3.61, PR 1.52 (1.43– 1.62).
3.3 | Older versus younger adults and 
prevalence trends
The registered prevalence of ASD, ADHD and ID all in-
creased from older (born 1967– 1983) to younger (born 
1984– 1997) adults (Table 2). Figure 2 shows the popula-
tion prevalence of ASD with and without comorbid ADHD 
and/or ID in males and females by birth year cohorts 
(Figure 2). ASD was the diagnosis with the largest change, 
increasing from 0.2% in adults born 1967– 1983 to 0.9% in 
adults born 1984– 1997. The rise was mainly accounted for 
by increasing prevalence of Asperger syndrome (AS) that 
was registered almost nine times as often in individuals 
born in the last 5- year period (1994– 1997) compared with 
the reference birth years (1967– 1973) (Figure  3). Older 
adults with ASD had a lower MFR than younger adults: 
2.36, PR 1.38 (1.34– 1.42) vs. 2.63, PR 1.41 (1.39– 1.43), al-
though with overlapping confidence intervals.
3.4 | Comparison with children
The MFR in the childhood population (4– 17 years old) with 
any ASD of 3.67, PR 1.54 (1.53– 1.56) was higher than in 
adults (Table  1). Similarly, younger children (4– 10  years 
old) had a higher MFR than older (11– 17 years old) chil-
dren, 4.46, PR 1.60 (1.57– 1.63) and 3.36, PR 1.52 (1.49– 
1.54), respectively. In the age group 4– 10  years old, the 
effect of concurrent ID was notable, with an MFR of 2.72, 
PR 1.26 (1.17– 1.35) in ASD with ID compared with 5.05, PR 
1.63 (1.60– 1.66) for ASD without ID. However, in both age 
groups (and in the total population of children), the MFRs 
and the PRs were higher in cases without concurrent ID.
3.5 | Variance in gender ratio according 
to ASD subtypes
The MFRs for different ASD subtypes (adults and children 
combined) are shown in Table 3. The highest MFR of 4.49, 
PR 1.60 (1.57– 1.63) was seen for childhood autism with-
out ID and the lowest MFR of 2.25, PR 1.22 (1.15– 1.29) 
was found for pervasive developmental disorder- not oth-
erwise specified (PDD- NOS) with ID (Table 3). The MFR 
for Asperger syndrome (AS) without ID was 2.98, PR 1.46 
(1.45– 1.55) (very few individuals overall were diagnosed 
with AS with ID (Table 3)).
4  |  DISCUSSION
We found a lower male to female ratio (MFR) for ASD in 
adults than in children. The highest MFR was found in 
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the youngest children (4– 10 years old), decreasing to the 
lowest MFR in older adults. Children with concurrent ID 
had a lower MFR than children with ASD alone, whereas 
children with ADHD and ASD had a higher MFR than 
in children with ASD alone, independent of concurrent 
ID. In adults, the presence of ID and ADHD had less im-
pact on the MFR. We found higher registered prevalence 
of ASD, ADHD and ID in younger than in older adults, 
with a registered ASD prevalence of 0.2% in older adults 
compared with 0.9% in younger adults.
Adult ASD is little studied, but childhood studies typ-
ically report more males with ASD than females, with an 
MFR of 4.25 in a meta- analysis from 2017.1 In the present 
study, we found a considerably lower MFR in adults than 
in children, in line with a small population study in the 
Faroe Island, but contrary to Brugha et al.16- 18 This was 
also true for Asperger syndrome (AS) where we found an 
MFR of 2.96 in adults, similar to a clinical study screening 
for ASD in adult psychiatric outpatients.25 AS has previ-
ously been thought of as a predominantly male disorder, 
with reports of up to ten males per female with AS in chil-
dren.26 In the current study, the MFR for AS was similar 
to other ASD diagnoses, indicating that some of the previ-
ously reported gender difference in AS may have been as-
certainment bias and under detection in females 1 in older 
studies. We found an equally steady increase in registered 
prevalence of AS with increasing 5- year age groups for 
both genders, with males being diagnosed 2– 3 times more 
frequently across all age groups, not supporting a better 
recognition of AS in females in the younger age groups. 
However, we were not able to discern from our data when 
the diagnosis was made, so it is still possible that recogni-
tion of female AS has improved.
Several findings in the current study indicate the pres-
ence of a gender bias in ASD diagnostic practice. Studies 
have shown that the MFR increases with increasing in-
tellectual level.1,17,27,28 In the current study, all but F84.8 
(PDD- OS) ASD diagnoses had a higher male PR for indi-
viduals without ID than with ID with the largest difference 
for childhood autism. This gender ratio gradient has led to 
the hypothesis that females may be protected against de-
veloping ASD and that a stronger developmental/genetic 
impact is needed for females to develop symptomatic ASD 
than for males.4 However, in the present study, we found 
larger differences in the MFR depending on ID in chil-
dren than in adults, so that the difference in the MFR for 
ASD with ID compared to without ID was largest in the 
youngest group, while there was no significant difference 
in MFR for adults. The smaller impact of concurrent ID 
on the male predominance in the older age groups could 
be because of later identification of ASD in females with-
out ID. The pattern of MFR variation according to ASD 
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be undiagnosed in the current sample, especially in higher 
functioning individuals,29 despite the relatively low MFR 
in the present study. The highest MFR was surprisingly 
found for childhood autism when excluding ID, while the 
lowest MFR was found for PDD- NOS including ID. This 
means that females are relatively more often diagnosed 
with the less specific diagnoses, ie that females are less 
often identified as having typical autism. Taken together, 
these findings indicate that although there may be a true 
gender difference, core ASD symptoms are also less well 
recognized in females, especially when not having comor-
bid intellectual disability. The pattern of registered ASD 
in childhood further supports this, as very few females in 
the youngest age group were diagnosed with ASD with-
out ID. The overall highest MFR of 6 times more males 
than females was found in the age group 4– 10 years old, 
for the combination ASD+ADHD without ID, indicating 
few girls are diagnosed early with neuropsychiatric symp-
toms unless they have concurrent ID. As found in other 
studies, these patterns indicate that a female with social 
difficulties is less likely to be perceived as having a clas-
sic autism phenotype in the absence of ID10 also in adult 
populations. Thus, despite a lower male to female ratio 
compared with previous studies, our findings still sup-
port the existence of a gender bias in this sample, where 
males are more easily diagnosed than females. It has been 
suggested that the standard for assessing ASD performs 
worse in females than in males as the items are modelled 
on the male phenotype.11 Brugha et al. also suspected as-
sessment and ascertainment bias to be part of the expla-
nation for their high ASD gender ratio among able adults, 
as they had a very low ASD ascertainment rate in females 
of normal intelligence and a very strong IQ gradient with 
ASD and gender.16,17 For ADHD, it has been shown that 
F I G U R E  1  Male prevalence ratio for 
children and adults with autism spectrum 
disorder (ASD), ASD with ADHD and 
ASD with intellectual disability (ID) 
compared with the corresponding 











All older adults 1,991 (0.2) 17,270 (1.9) 3,356 (0.4)
Men 1,399 (0.3) 9,433 (2.0) 1,701 (0.4)
Women 592 (0.1) 7,837 (1.7) 1,655 (0.4)
All younger adults 7,004 (0.9) 36,552 (4.7) 5,822 (0.7)
Men 5,075 (1.3) 22,662 (5.7) 3,193 (0.8)
Women 1,929 (0.5) 13,890 (3.7) 2,629 (0.7)
Abbreviations: ADHD, attention- deficit/hyperactivity disorder; ASD, Autism spectrum disorder; ID, 
intellectual disability.
T A B L E  2  Prevalence of Norwegian 
Patient Registry diagnoses of ASD, ADHD 
and ID in older (born 1967– 1983) versus 
younger adults (born 1984– 1997), Norway, 
diagnoses from 2008– 2015
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female gender is a strong barrier to child mental health 
services, assessment and adequate management for neu-
ropsychiatric disorders at every level among children and 
adolescents, whereas adult studies show an almost equal 
MFR and even lower than 1 in some cases,12,30 suggesting 
that females receive the ADHD diagnosis later in adoles-
cence and adulthood. Childhood studies have also found 
that females with mental health problems have lower 
chances for being in contact with mental health services,31 
and in autism symptom high scorers, girls required a 
much higher symptom load to be viewed as impaired.32 
The findings of the present study and the study from the 
Faroe Islands where they found more females with ASD 
in the second assessment (older adolescents and adults) 
than in the first assessment suggest the same diagnostic 
delay could apply for females with ASD. Furthermore, as 
impairment is crucial to the diagnosis, females may first 
seek help and/or fulfil diagnostic criteria when encoun-
tering more complex demands in adulthood requiring so-
cial skills (eg childrearing). It is also well known that in 
adulthood, females seek health services more often than 
males, which could contribute to a reversal of the diag-
nostic bias in adulthood.33- 35 The somewhat surprising 
finding in the present study of a relatively lower MFR for 
AS than for childhood autism could support this hypoth-
esis, as first- time diagnosed adults would preferentially 
F I G U R E  2  Population prevalence of 
ASD with and without comorbid ADHD 
and/or ID in males and females by birth 
year cohorts
F I G U R E  3  Population prevalence of 
Asperger syndrome (AS) in adult males 
and females by birth year cohorts
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be diagnosed with AS (a diagnosis of childhood autism 
requires established developmental deviances before the 
age of three).
The increase of registered ASD from older to younger 
adults was quite dramatic but is in line with the changes 
in diagnostic practice in the last decades, with increasingly 
higher prevalence rates of ASD registered in later years.36 
The increase was mainly accounted for by the addition of 
Asperger syndrome (AS) as a separate diagnosis in 1994, 
with a very clear effect on the registered prevalence of AS 
diagnoses. It was also by far the most common diagno-
sis of the ASD spectrum, accounting for 60% of all ASD 
cases (Table 3 and Figure 3). The overall registered preva-
lence and the increase of AS diagnoses indicate that ASD 
should not be considered an uncommon disorder in adult-
hood, nor a disorder limited to childhood. The registered 
prevalence of 0.9% ASD among younger adults stands in 
contrast to the paucity of research on this condition in 
adulthood. Viewed as a childhood condition, adults with 
ASD are standing with unmet healthcare needs and few 
evidence- based interventions to resort to.37,38 The 0.9% 
prevalence is probably a low estimate of the prevalence 
worldwide as Norwegian studies often report lower preva-
lence rates than other countries.39 In the current study, the 
child ASD prevalence was 1.4% while recent USA and UK 
studies report prevalence rates above 2%.2,36 However, the 
gender distribution in this study was almost identical to 
the findings in Roman- Urrestarazu et al., indicating that 
the gender discrepancy is present regardless of diagnostic 
restrictive or liberal practice.2
4.1 | Strengths and limitations
A strength of our study is that we used data from nation-
wide health registries of good quality and with manda-
tory, prospective reporting, minimizing selection bias and 
loss to follow- up and eliminating recall bias. However, 
this study also has some limitations. Analyses were 
cross- sectional and for ASD and ID, these were based on 
diagnoses registered in the NPR from 2008– 2015, limit-
ing the study of temporal relations. ASD and ID are both 
neurodevelopmental disorders where diagnoses are usu-
ally given in childhood. Since the NPR was established in 
2008, adults with stable disorders, who were diagnosed 
and treated for ASD and ID entirely before 2008 and not 
in contact with specialized health services after that, will 
not appear in the clinical population. It is therefore im-
possible to draw any firm conclusions as to the magni-
tude of prevalence difference between older and younger 
adults. Further, we could only determine the date of the 
registered diagnosis in NPR in the 2008– 2015 interval, so 
to construct the ‘adult population’ we based this on the 
individuals’ age in 2015 (at record linkage) instead of 
their age at diagnosis. This means that an adult born in 
1997 would have been counted in the present study as an 
adult with ASD even if diagnosed in childhood. However, 
since ASD and ID are stable diagnoses across the lifes-
pan,40,41 the majority will have retained their diagnosis 
as adults. For ADHD however, the adult prevalence may 
have been overestimated because of this limitation, but as 
adult ADHD was also based on age at dispensed ADHD 
medication, this should not be a large problem. The lack 
of information on other comorbidities, eg epilepsy, is an-
other limitation.
Only including diagnoses registered on individuals 
who were in contact with specialist health services at 
any point in time 2008– 2015 (or a prescription for ADHD 
medicine 2004– 2015) may furthermore cause some spe-
cific biases in the male to female ratio estimates and prev-
alence registered. For individuals where the diagnostic 
assessment of ASD was before 2008, the NPR will only 
capture the ASD diagnosis when individuals seek spe-
cialist health care for later concerns, and health- seeking 
behaviours in males and females are known to differ. 
Secondly, we were not able to consider the increased 
mortality associated with ASD, ID and ADHD, which has 
also been found to be differential between males and fe-
males.42 Furthermore, less disabled individuals may not 
have their ASD diagnosis registered when seeking health 
care for other matters, underestimating the registered 
prevalence of ASD especially in older well- functioning 
individuals. Thus, the overall registered ASD prevalence 
of 0.5% in this adult sample is probably an underestima-
tion of the ASD prevalence in adults. Furthermore, al-
though the register has national coverage only includes 
formal diagnoses made in the specialized health services, 
thus individuals with subthreshold or unrecognized ASD 
is not part of the register.
According to DSM- IV and ICD- 10, a diagnosis of ASD 
precludes ADHD. This may have affected the diagnostic 
procedures and hindered the clinician to give both disor-
ders whether the criteria were fulfilled. This diagnostic 
practice has changed gradually even before the advent of 
DSM- 5 and is likely to explain the far lower number of 
individuals with comorbid ADHD and ASD disorder in 
older adults.
The adult ASD male to female ratio (MFR) was lower 
than the MFR in children and less affected by comorbid 
ID. Females were more likely to be diagnosed with atyp-
ical autism and PDD- NOS, and in childhood, if they had 
concurrent ID, supporting the existence of a male pheno-
type bias in the diagnosing of ASD. An overall registered 
prevalence of ASD of 0.9% among younger adults shows 
that ASD is becoming relatively common, warranting fur-
ther research on this condition in adulthood.
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